NCT00129870View on ClinicalTrials.gov

CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer

PHASE4TerminatedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

December 31, 2007

Conditions

Colorectal Cancer

Interventions

DRUG

oxaliplatin

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00129870 - CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter